To evaluate the cellular activity of BDM19, we tested its ability to promote apoptotic cell death in various lymphoma and leukemia cell lines expressing either cytosolic BAX monomer (e.g. HPB-ALL) or dimer (e.g. SUDHL-5) (Fig. 1b). This evidence concerns the gene BAX and leukemia.